Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental Pseudomonas pneumonia

Journal of Infectious Diseases

Volumn 158, Issue 1, 1988, Pages 7-12

  Kapusnik, J E ^a   Hackbarth, C J ^a   Chambers, H F ^a   Carpenter, T ^a   Sande, M A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERICIDE; MEZLOCILLIN; TOBRAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL COUNT; DRUG BLOOD LEVEL; DRUG DOSE; DRUG EFFICACY; EXPERIMENTAL INFECTION; GUINEA PIG; INTRAMUSCULAR DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0023779917     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/158.1.7     Document Type: Article

References (0)